All News

After 10 years women’s median earnings are 9% less than men’s.

Contemporary OB/GYN® Associate Editor Lindsey Carr sat down with Jessica Shim, MD, an attending at in the Division of Gynecology, Department of Surgery, Boston Children’s Hospital; Harvard Medical School Boston, Massachusetts, to discuss Myfembree (relugolix, estradiol, and norethindrone acetate tablets; Myovant Sciences, Pfizer) and its possible approval in May 2022.

About 1 in 5 girls with pediatric type 2 diabetes (T2D) also has polycystic ovary syndrome (PCOS), according to a systematic review and meta-analysis in JAMA Network Open.

A quality improvement study in JAMA Network Open has found that a significantly lower percentage of patients with breast cancer presented with stage I disease before the COVID-19 pandemic, in 2019, compared to after the start of the pandemic, in 2020.

COVID-19 updates and news to know as of February 21, 2022.

The American Urogynecologic Society (AUGS) published an executive summary on postoperative opioid prescribing after female pelvic medicine and reconstructive surgery.

Twenty-nine HRSA-funded health centers to receive a boost in technology to improve outcomes.

Stopping some doctors from sharing unsound medical advice has proved challenging. Even defining misinformation has been difficult. And during the pandemic, resistance from some state legislatures is complicating the effort.

Dr. Lorna Breen Health Care Provider Protection Act aims to help physicians receive mental health assistance without jeopardizing their licenses.

Cancer misinformation may be more prevalent among residents in rural vs urban areas, study finds.

Risk factors for the dual burden of severe maternal morbidity and preterm birth differ significantly by insurance type across sociodemographic and perinatal considerations in the state of California, according to a study in the Maternal and Children Health Journal.

Patients with acute vulvovaginal candidiasis (VVC) greatly benefited from oral ibrexafungerp (Brexafemme, Scynexis), according to results of a global phase 3 randomized, double-blind, placebo-controlled superiority study published in the international journal of obstetrics and gynecology, BJOG.

Many new therapies have been developed over the past decade to treat disorders that are often present at birth and early treatment can lead to better outcomes. However, the screenings for newborns have been slow to adapt.

Patients with endometriosis are nearly four times as likely to develop rheumatoid arthritis (RA) than those without endometriosis, according to a study in the Journal of Women’s Health.

The NVX-CoV2373 vaccine was evaluated in adolescents aged 12 to 17 years.

Postmenopausal vaginal symptom severity is not significantly linked to vaginal microbiota or mucosal inflammatory markers, according to a small study in the American Journal of Gynecology & Obstetrics.

Just 14.3% of hospitals complying with rule meant to encourage consumer price shopping.

Robert Califf was approved in a 50-46 vote by the senate.

This is the first time in 18 years that financial challenges were not the top issue.

Prior authorizations are an obvious obstacle for physicians, but it also negatively impacts employers.

A look at what's coming to Contemporary OB/GYN this week

The safety of the Pfizer/BioNTech COVID-19 vaccine in pregnant women, for both mother and baby, has been dependent on observation during the rollout. A large population trial provides further support for the vaccine’s safety.

In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.

A 4-year follow-up of a randomized control study comparing uterine artery embolization (UAE) to myomectomy for treating women with uterine fibroids has concluded that myomectomy achieves greater improvement in quality of life.

A study in the Journal of Minimally Invasive Gynecology concluded that, in select pateints with deep infiltrating endometriosis (DIE) whom do not require bowel or ureteral resection, bladder function significantly improves after surgery, both during filling and in voiding urodynamic phases.

Uterine fibroids (UF) with heavy menstrual bleeding (HMB) pose a significant economic burden—mostly due to surgical and procedural costs and treatment, according to a claims analysis in the Journal of Women’s Health.

A look back on this week's news.

Scynexis released data from its pivotal Phase 3 CANDLE study of oral ibrexafungerp (BREXAFEMME) for the prevention of recurrent vulvovaginal candidiasis.